Enhance your portfolio

We couldn’t do what we do without the support of you – the clinicians who work so hard to make life better for people who are living with a brain tumour. We’re none of us as smart as all of us – and so we want to make sure we are working with clinicians as much as possible. If you’d like to get closer to our brain tumour community read on – we’d be delighted to hear from you.

Coaching is at the heart of the service we provide at brainstrust. It provides patients and their caregivers a space to come to their own conclusions and make decisions about their care that are right for them. Patients and caregivers who are resilient, resourced and who ‘own’ the diagnosis have better consultations with you, have better outcomes and are more comfortable living with uncertainty. Their inner voice is constructive – they may even share insights with you which are surprising.

Find out more about coaching and how it compares to counselling, which we also offer for people with a brain tumour.

Review resources for people with a brain tumour

As well as working with the people we support, we build close relationships with healthcare professionals and scientific advisers from across the UK to ensure that we have the perspective needed to tackle the complex challenges that the brain tumour community face.

I was familiar with brainstrust as they had visited our department and shown me the support they offer patients. I was happy to assist when they asked me to review a paediatric leaflet. I was pleased I could directly benefit patients and families from around the country. Explaining procedures and treatments like radiotherapy to children in a way they can understand will reduce their anxiety and improve their overall experience. When I saw the end result I was delighted to be a small part of such a brilliant book that will help so many children. 

Paediatric and Teenage Young Adult Radiographer

An integral part of the work that healthcare professionals assist us with is reviewing our resources. This helps us ensure that our information is expertly accurate and relevant. If this is something you would like to get involved in, please email hello@brainstrust.org.uk

Speak at our events

Our Thrive events provide a deep dive into different aspects of life with a brain tumour, so that attendees feel more engaged with their care and condition, more resourced to deal with the issues they face and less uncertain and fearful about the future. For relevant topics, a key part of these events involves giving attendees opportunities to ask questions and hear directly from a clinician. If there is a topic you would like to discuss at one of our events, please get in touch by emailing hello@brainstrust.org.uk

Hosting these webinars was a fantastic opportunity to be able to engage the brain tumour community in conversation; debunking myths and providing appropriate support and accurate information. Being able to host these sessions online means we are able to reach out to a much wider audience. My sessions were well attended and well received and I have been able to collate this feedback for my CPD portfolio.

Rhona Watson, Consultant Therapeutic Radiographer

Topics covered in the past include:

  • Cannabinoids
  • Diet and nutrition
  • Developments in neurosurgery
  • The latest neuro-oncology clinical trials
  • Immunotherapy

Visit our event calendar to see what we have coming up.

Help us help others

The work we do is only made possible by the generous support of our community. If you and your patients have found brainstrust to be helpful, please consider donating or fundraising so that we can be here for everyone that needs us.

Keeping in touch

Opt in to be the first to hear about new resources, the latest on patient centred care, events for your own development, events for your patients and opportunities to engage in policy and direction setting.Opt in to hearing from brainstrust

Latest news for clinicians

1 2 3 4 5 6 7 8 9 ...
page 1 of 414

Introduction

The Brain Tumour Data Dashboard lets you explore up -to-date, population level data about the brain tumours diagnosed in England between 2013 and 2015. Using the drop down menus on the left you can select different groups of patients to view in the charts below. In these charts the number of patients for every 100 diagnoses is displayed as images of people. Patients have been grouped by date of diagnosis, type of tumour, age, gender, and region in England.

For each group of patients you can explore the different routes to diagnosis, the proportion of those who received chemotherapy or radiotherapy, as well as the survival of the patients within each group. For more information about what these metrics mean please see the glossary.

How to use

  1. Select the year of diagnosis using the drop down menu.
  2. Select your patient group of interest from the four drop down menus in the following order:
    1. Tumour group
    2. Age at diagnosis
    3. Region of England
    4. Gender of patient
  3. To view a second chart to compare different groups of patients, click the ‘compare’ button.The second chart will appear below the first chart.

*Note that the tool is best used on a laptop or tablet rather than a mobile phone*

Unavailable data

Some of the data in these charts is not available.There are two main reasons for this:

  1. How the data has been grouped

If you cannot select a patient group from the drop down menus, the data is unavailable because of how the data has been organised.

Public Health England has grouped the data like a branching tree. The bottom of the tree contains all the patients with brain tumours, and then each branch divides the data by a certain characteristics, like age, or location of tumour. But the data is divided in an order, starting with location of the tumour (endocrine or brain), then by age, region, and gender. Age is at the start because it makes a bigger difference to survival rates and treatment rates than gender or region. Sometimes, after the data has been split by type of tumour and age, there is not enough data to be split again. This is because to protect patient confidentiality groups cannot contain less than 100 patients. Because some groups cannot be split further, you cannot create ‘totals’ for everyone by region or gender. For example, you cannot see results for all ages by region, or all brain tumours by gender. If these totals were calculated and released, it might be possible to identify patients, which is why Public Health England cannot release this data.

  1. Statistical reasons and data availability

If you can select a patient group from the chart menus, but the chart does not display, the data is unavailable for one of several reasons:

  1. Data is not yet available for the selected year from Public Health England.
  2. Data is not available because the data quality is too poor to release this statistic.
  3. Data is not available as the statistic is not appropriate for this group.
  4. Data is not available because the standard error of the estimate was greater than 20% and so the estimate has been supressed.

Up to date brain tumour data

Brain tumour data may influence the decisions you make about your care. Data also helps you understand the bigger picture, or landscape, in which you find yourself.

Brain tumour data and statistics influence the focus, and work of organisations like brainstrust. The information helps us to understand the scale and impact of the problems we are setting out to solve.

This tool helps you understand the landscape in which you find yourself having been diagnosed with a brain tumour. This landscape can be particularly tricky to navigate as there are many different types of brain tumour, all of which have a different impact.

The information you see represents the most up-to-date, official, population level brain tumour data available for England. Over time we will be adding to the brain tumour data available and publishing reports, with recommendations, as a result of what we learn from this data.

The data behind this content has come from Public Health England’s National Cancer Registration and Analysis Service (NCRAS) and is a direct result of the ‘Get Data Out’ project.

This project provides anonymised population level brain tumour data for public use in the form of standard output tables, accessible here: http://cancerdata.nhs.uk/standardoutput

Incidence

The number or rate (per head of population) of new cases of a disease diagnosed in a given population during a specified time period (usually a calendar year). The crude rate is the total number of cases divided by the mid-year population, usually expressed per 100,000 population.

Malignant

Malignant tumours which grow by invasion into surrounding tissues and have the ability to metastasise to distant sites

Mortality

The number or rate (per head of population) of deaths in a given population during a specified time period (usually a calendar year). The crude rate is the total number of deaths divided by the mid-year population, usually expressed per 100,000 population.

Non-malignant

Not cancerous. Non-malignant tumours may grow larger but do not spread to other parts of the body.

Survival

The length of time from the date of diagnosis for a disease, such as cancer, that patients diagnosed with the disease are still alive. In a clinical trial, measuring the survival is one way to see how well a new treatment works. Also called ‘overall survival’ or ‘OS’.

Routes to Diagnosis

Under the ‘Routes to Diagnosis’ tab in the Brain Tumour Data Dashboard, you can explore the ways patients have been diagnosed with brain tumours. There are many ways, or routes, for cancers to be diagnosed in the NHS. A ‘route to diagnosis’ is the series of events between a patient and the healthcare system that leads to a diagnosis of cancer. The routes include:

  1. Two Week Wait

Patients are urgently referred by their GP for suspected cancer via the Two Week Wait system and are seen by a specialist within 2 weeks where they are diagnosed.

  1. GP referral

Diagnosis via a GP referral includes routine and urgent referrals where the patient was not referred under the Two Week Wait system.

  1. Emergency Presentation

Cancers can be diagnosed via emergency situations such as via A&E, emergency GP referral, emergency transfer or emergency admission.

  1. Outpatient

Outpatient cancer diagnoses include diagnoses via an elective route which started with an outpatient appointment that is either a self-referral or consultant to consultant referral. (It does not include those under the Two Week Wait referral system).

  1. Inpatient elective

Diagnosis via an inpatient elective route is where diagnosis occurs after the patient has been admitted into secondary care from a waiting list, or where the admission is booked or planned.

  1. Death Certificate Only

Diagnoses made by Death Certificate Only are made where there is no more information about the cancer diagnosis other than the cancer related death notifications. The date of diagnosis is the same as that of the date of death.

  1. Unknown

For some patients with a cancer diagnosis, there is no relevant data available to understand the route to diagnosis.

 

More information

If any of the statistical terms in this section of the brainstrust website are hard to understand, we recommend looking them up here:

Cancer Research UK’s Cancer Statistics Explained

http://www.cancerresearchuk.org/health-professional/cancer-statistics/cancer-stats-explained/statistics-terminology-explained#heading-Seven

If you are looking for help understanding terms relating specifically to brain tumours, and treatment, then the brainstrust glossary is available here:

https://www.brainstrust.org.uk/advice-glossary.php